Interaction of miconazole, ketoconazole and itraconazole with rat-liver microsornes

References

• ENGEL, P. C., 1984, Enzyme kinetics. In The Chemistry of Enzyme Action, edited by M. I. Page (Amsterdam, New York, Oxford: Elsevier), pp. 89–90.
   Google Scholar
• HAJEK, K. K., and NOVAK, R. F., 1982, Spectral and metabolic properties of liver microsomes of imidazole-pretreated rats. Biochemical and Biophysical Research Communications, 108, 664–672.
   PubMed Web of Science ®Google Scholar
• HAJEK, K. K., COOK, N. I., and NOVAK, R. F., 1982, Mechanism of inhibition of microsomal drug metabolism by imidazole. Journal of Pharmacology and Experimental Therapeutics, 223,97–104.
   PubMed Web of Science ®Google Scholar
• HEEL, R. C., BROGDEN, R. N., PAKES, G. E., SPEIGHT, T. M., and AVERY, G. S., 1980, Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs, 19, 7–30.
   PubMed Web of Science ®Google Scholar
• IMAI, Y., ITO, A., and SATO, R., 1966, Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. Journal of Biochemistry, 60, 417–428.
   PubMed Web of Science ®Google Scholar
• LENK, W., 1976, Application and interpretation of kinetic analyses from the microsomal drug metabolizing oxygenases. Biochemical Pharmacology, 25,997–1005.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H. ROSEBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MASON, J. I., MURRAY, B. A., OLcorr, M., and SNErrs, J. J., 1985, Imidazole antimycotics: inhibitors of steroid aromatase. Biochemical Pharmacology, 34, 1087–1092.
   PubMed Web of Science ®Google Scholar
• MEREDITH, C. G. MALDONADO, A. L., and SPEEG, K. V., 1985 a, The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro. Drug Metabolism and Disposition, 13, 156–162.
   PubMed Web of Science ®Google Scholar
• MEREDITH, C. G., SPEEG, V. K., and SCHENICER, S., 1985 b, Nizatidine, a new histamine H2-receptor antagonist, and hepatic oxidative drug metabolism in the rat: a comparison with structurally related compounds. Toxicology and Applied Pharmacology, 77, 315–324.
   PubMed Web of Science ®Google Scholar
• MILLER, G. L., 1959, Protein determination for large numbers of samples. Analytical Chemistry, 31,964.
   Web of Science ®Google Scholar
• NASH, T., 1953, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal, 55, 416–421.
   PubMed Web of Science ®Google Scholar
• NETTER, K. J., and SEIDEL, G., 1964, An adaptively stimulating O-demethylating system in rat liver microsomes and its kinetic properties. Journal of Pharmacology and Experimental Therapeutics, 146, 61–64.
   PubMed Web of Science ®Google Scholar
• NIEMEGEERS, C. J. E., LEVRON, J. C., AWOUTERS, F., and JANsseN, P. A. J., 1981, Inhibition and induction of microsomal enzymes in the rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole. Archives Internationales de Pharmacodynamie et de Thirapie, 251,26–38.
   PubMedGoogle Scholar
• OMURA, T., and SKr°, R., 1964a, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its haemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   Google Scholar
• OMURA, T., and SATO, R., 1964b, The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification and properties. Journal of Biological Chemistry, 239, 2379–2385.
   PubMed Web of Science ®Google Scholar
• PECK, C. C., BE.AL, S. L., SHEINE.R, L. B., and NICHOLS, A. I., 1984, Extended least squares non-linear regression: a possible solution to the 'choice of weights' problem in analysis of individual pharmacokinetic data. Journal of Pharmacokinetics and Biopharmaceutics, 12, 545–558.
   Google Scholar
• RENDIC, S., Simpc, V., Togo, R., KAptz, F., and RUE', H.-H., 1979, Interaction of cimetidine with liver microsomes. Xenobiotica, 9, 555–564.
   Google Scholar
• ROGERSON, T. D., WILKINSON, C. F., and HETNARSKI, K., 1977, Steric factors in the inhibitory interaction of imidazoles with microsomal enzymes. Biochemical Pharmacology, 26, 1039–1042.
   PubMed Web of Science ®Google Scholar
• SCHENKMAN, J. B., REMMER, H., and ESTABROOK, R. W. E., 1967, Spectral studies of drug interaction with hepatic microsomal cytochrome. Molecular Pharmacology, 3, 113–123.
   PubMed Web of Science ®Google Scholar
• SCHENKMAN, J. B., SUGAR, S. G., and CINTI, D. L., 1981, Substrate interaction with cytochrome P-450. Pharmacology and Therapeutics, 12, 43–71.
   PubMed Web of Science ®Google Scholar
• SCHUSTER, I., 1985, The interaction of representative members of antimycotics—the az,oles and the allylamines—with cytochrome P-450 in steroidogenic tissues and liver. Xenobiotica, 15, 529–546.
   PubMed Web of Science ®Google Scholar
• SHEETS, J. J., and MASON, J. I., 1984, Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. Drug Metabolism and Disposition, 12,603–606.
   PubMed Web of Science ®Google Scholar
• STIER, A., 1976, Lipid structure and drug metabolizing enzymes. Biochemical Pharmacology, 25, 109–113.
   PubMed Web of Science ®Google Scholar
• SYMOENS, J., 1977, Clinical and experimental evidence for the treatment of systemic mycoses: a review. Proceedings of the Royal Society of Medicine, 70 (suppl. 1), 4–8.
   PubMedGoogle Scholar
• TRACHTENBERG, J., and PONT, A., 1984, Ketoconazole therapy for advanced prostate cancer. The Lancet, (August), 433–435.
   Google Scholar
• VAN CUTSEM, J., and JANSSEN, P. A. J., 1985, Nouveaux antimyconiques: activite in vitro et in vivo. Rulletin de la Société Franeaise de Myeologie Midicale, 14, 131–140.
   Google Scholar
• VANDEN BOSSCHE, H., 1985, Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. In Current Topics of Medical Mycology, edited by M. R. McGinnis (New York: Springer Verlag), pp. 313–351.
   Google Scholar
• VANDEN BOSSCHE, H., LAUWERS, W., WILLEMSENS, G., MARICHAL, P., CORNELISSEN, F., and COOLS, W., 1984a, Molecular basis for the antimycotic and antibacterial activity of N-substituted imidazoles and triazoles. The inhibition of isoprenoid biosynthesis. Pesticide Science, 15, 188–198.
   Google Scholar
• VANDEN BOSSCHE, H., WILLEMSENS, G., COOLS, W., MARICHAL, P., and LAUWERS, W., 1983, Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. Biochemical Society Transactions, 11, 665–667.
   PubMed Web of Science ®Google Scholar
• VANDEN BOSSCHE, H., WILLEMSENS, G., MARICHAL, P., CooLs, W., and LAUWERS, W., 1984b, The molecular basis for the antifungal activities of N-substituted azole derivatives. Focus on R 51 211. In Mode of Action of Antifungal Agents, edited by A. P. J. Trinci and J. F. Ryley (Great Britain: British Mycological Society), pp. 321–341.
   Google Scholar
• VAN TYE, H. J., 1984, Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy, 4, 343–373.
   PubMed Web of Science ®Google Scholar
• WILKINSON, C. F., and FltrrNAnsm, K., 1974, Structure-activity relationship in the effects of 1-alkyl imidazoles on microsomal oxidation in vitro and in vivo. Biochemical Pharmacology, 23,2377–2386.
   PubMed Web of Science ®Google Scholar
• WILKINSON, C. F., HETNARSKI, K., and YELLIN, T. O., 1972, Imidazole derivatives—a new class of microsomal enzyme inhibitors. Biochemical Pharmacology, 21, 3187–3192.
   PubMed Web of Science ®Google Scholar